Daily Stock List
HotOTCPicks.com, OTCReporter, OTCPennyPicks.com, OTCNewsAlerts.com, JumpingPennyStocks.com, HotPennyInvest.com, HotOTCChina.com, and HotOTCBuzz.com reported previously on ZAP (ZAAP), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
ZAP, in union with its subsidiaries, engages in the design, development, manufacture, and sale of electric vehicles primarily in the U.S. ZAP Jonway stands for ZAP and its subsidiary company in China, Jonway Automobile. ZAP Jonway combines the attributes of its parent subsidiary companies to design and manufacture quality, affordable, gasoline and electric vehicles (EVs), also called new energy vehicles. ZAP Jonway is based in Santa Rosa, California. Jonway Auto is based in Zhejiang Province, China.
ZAP is an early pioneer of EVs and it brings to both companies a broad array of EV design experience, which it applies to its new product lines. Jonway Automobile has ISO 9000 manufacturing facilities, engineering, sales and customer service facilities in China.
ZAP Jonway has production capacity of up to 50,000 vehicles per year, and has a sales distribution network in China. ZAP Jonway benefits from the established China dealership and customer support network developed by Jonway Automobile for its China sales and services.
ZAP Jonway is focusing on addressing EV fleets targeting city deliveries trucks and vans used by university campuses, government, as well as corporate markets in China and the U.S. This is while employing its gasoline vehicle production quantities to gain economy of scale through its common vehicle parts and platforms. ZAP Jonway’s traditional gasoline vehicles are distributed across 30 countries.
ZAP’s subsidiary, Jonway Auto, has its 5-Star MiniVan EV. This Minivan EV represents one of three EV models launched for China and international markets. The other two models are the 3-Door E380 SUV, and the 5-Door E-Falcon SUV. The 5-Star Minivan EV represents the first lithium battery full electric minivans in China.
Jonway Auto also has its small EV sedan, SPARKEE for city commuters in China. SPARKEE comes in two models: the lead acid version, which has a lower range of 120 km, and the lithium version, which has a longer range of over 180 km between charges.
ZAP unveiled in 2014 the smallest family in its EV product line - the Urban EV, "URBEE." This is a city utility fleet EV targeting Chinese city municipal vehicles and local city commuters.
Recently, ZAP and Jonway Auto reported the signing of an OEM contract on February 2, 2015 for 5000 units of ZAP Jonway's EV Minivans that will sell under the brand of Dong Feng Motor Corp., one of the leading Auto enterprise groups in China via its partner Shi Kong (SKIO Matrix) Electric Vehicle Company, headquartered in Hangzhou, Zhejiang Province. Shi Kong is the integrator and agent for Jonway's EV minivan to Dong Feng Automobile, one of the top four state owned auto manufacturers in China and the second automobile company created by the Chinese government.
ZAP Jonway's EV minivan will be typed approved as a delivery van with the enhanced battery capacity specified by Dong Feng Motor and integrated by its partner Shi Kong. Dong Feng is the joint venture partner of Honda, Nissan and Citroen/Peugeot.
ZAP (ZAAP), closed Thursday's trading session at $0.0785, down 1.88%, on 337,151 volume with 38 trades. The average volume for the last 60 days is 128,130 and the stock's 52-week low/high is $0.0701/$0.28.
Eco-Shift Power Corp. (ECOP)
PennyStocks24, BestDamnPennyStocks, Penny Stock Circle, 1-2-3 Stock Alerts, StockMister, OTCBB Journal, Club Penny Stocks Network, and Bull Trends reported earlier on Eco-Shift Power Corp. (ECOP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Eco-Shift Power Corp. develops best-in-class commercial/industrial lighting products, wireless energy management technologies, and solutions implementation. It is an emerging technology smart building energy management facilitator. Its core competencies include LED high bay lighting, wireless energy management systems that are plug-and-play and compatible with multiple technologies, and software platforms that allow for automated demand management and demand response. Eco-Shift Power has its headquarters in Cambridge, Ontario.
Essentially, Eco-Shift Power is a high efficiency lighting retrofit specialist and manufacturer of LED lighting products, wireless energy management systems, and cloud based software platforms. Eco-Shift helps major industrial, commercial and institutional energy users attain energy and environmental footprint reduction and sustainability. It creates substantial operating cost savings through the application of proven, cost effective technologies.
Eco-Shift Power acquires, assembles, sells and distributes high-efficiency lighting products, together with other integrated energy management products. These other products include online monitoring and verification reporting tools, direct load controls, activity monetization instruments, and demand response. All are delivered via Software-as-a-Service (SaaS).
Eco-Shift Power’s business model includes three primary segments. One is EPC (engineering/design, procurement, construction) of diversified and large scale lighting retrofit projects. Another is OEM (original equipment manufacturer) of LED lighting and wireless energy management systems. The third is Energy Management and Demand Response, provided through long-term contracts and a Software-as-a-Service (SaaS).
In October 2014, Eco-Shift Power announced the milestone acquisition of Sun & Sun Industries, Inc. dba Sun Industries. The definitive Share Purchase and Exchange Agreement closed on October 20, 2014 and resulted in Eco-Shift acquiring 100 percent of the issued and outstanding common stock of Sun Industries and the cancellation of all outstanding Sun Industries Preferred Stock. Sun Industries of Santa Ana, California, is a diversified design-build lighting retrofit and energy management company.
Today, Eco-Shift Power announced that its wholly-owned subsidiary, Sun & Sun Industries (Sun Industries), secured the development phase of a 38 site project scheduled to commence this quarter in Washington State. This project starts, while a statewide rollout of turnkey energy efficient lighting projects in Utah and Wyoming beginning in December 2014 continues. Sun Industries was awarded both states totaling 16 branches and more than 1,700 fixtures and has further been awarded these additional 38 sites in Washington. This builds on an existing relationship with a total amount of developed and completed lighting retrofit projects of more than 200 sites across eight states. So far, more than $1.5 million of lighting retrofit work has been completed for this customer.
Eco-Shift Power Corp. (ECOP), closed Thursday's trading session at $0.0801, up 17.62%, on 116,806 volume with 19 trades. The average volume for the last 60 days is 31,988 and the stock's 52-week low/high is $0.0354/$0.92.
OriginOil, Inc. (OOIL)
SuperStockTips, Beacon Equity Research, Penny Stock Craze, Investor Soup, Stock Preacher, and Penny Stocks Finder reported earlier on OriginOil, Inc. (OOIL), and we report on the Company today, here at the QualityStocks Daily Newsletter.
OriginOil, Inc. is the developer of a unique energy production process for harvesting algae and cleaning up oil & gas water. This process operates at the first stage of extraction. The high-speed and chemical-free process can be embedded in other systems to improve performance. The Company has developed an innovative process for removing up to 99 percent of contaminants from the very large quantities of water used by the oil & gas, algae, and other water-intensive industries.
The foundation of its CLEAN-FRAC process is on its Electro Water Separation™ (EWS) technology. This technology efficiently removes oils, suspended solids, insoluble organics, and bacteria from produced or 'frac flowback' water, on a continuous flow basis and without the use of chemicals. EWS is the high-speed, chemical-free process to clean up large quantities of water.
The Company’s EWS works in two parts. First, contaminated water enters the first stage, Electro-Coagulation (EC). In this stage, electrical impulses are applied in long tubes, causing the organic contaminants to coagulate, or “clump” together. In 2009, OriginOil branded this stage Single-Step Extraction™. Second, the clumped-up material travels into a tank where electrical pulses generate a cloud of micro-bubbles that gently lifts the concentrate to the surface for harvesting.
CLEAN-FRAC™ is a complete solution. It can be designed for enhanced oil recovery, hydraulic fracturing operations, irrigation water, and potable water. It begins with OriginOil’s core EWS technology to remove oil, solids and bacteria, and adds downstream processes to attain the desired result.
For the oil & gas industry, OriginOil is helping clean up produced water and recycle fracking water to reduce harm to the environment and lower costs. For the developing algae industry, it is making large-scale harvest possible. Additionally, in aquaculture, the Company is helping improve yields and making seafood healthier through significantly lessening the levels of toxic ammonia and bacteria in water.
OriginOil has now launched the Smart Algae Harvester™ line of low-energy algae concentrators. The first model in the new line is the A25. This is a mainstay algae harvester designed for scale-up testing and initial production. A25 can process up to 25 liters per minute, or up to 36,000 liters (around 10,000 gallons) of algae cultivation water per day.
Today, OriginOil announced that the Company is now named OriginClear™, Inc., effective immediately. Its ticker symbol, OOIL, will remain unchanged.
Mr. T. Riggs Eckelberry, Chief Executive Officer of the newly named OriginClear, said “As our company has grown, we've learned that our technology can serve a vast number of markets in need of innovative water cleanup solutions. The new name, OriginClear, reflects our proven ability to treat water to a very high level of clarity.”
OriginOil, Inc. (OOIL), closed Thursday's trading session at $0.082, up 46.69%, on 3,944,130 volume with 356 trades. The average volume for the last 60 days is 567,143 and the stock's 52-week low/high is $0.0502/$0.2388.
Relmada Therapeutics, Inc. (RLMD)
StreetAuthority Financial, Investors Alley, Dividend Opportunities, Wallstreetbuzz, Investopedia, ProfitableTrading, and WallstreetsHotteststocks reported earlier on Relmada Therapeutics, Inc. (RLMD), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Relmada Therapeutics, Inc. is a clinical-stage, specialty pharmaceutical company listed on the OTCQB. The Company focuses on developing novel versions of proven drug products in combination with new chemical entities that potentially address areas of high unmet medical need in the treatment of pain. Relmada Therapeutics is headquartered in New York, New York.
The Company has a varied portfolio of four lead products at different stages of development. These products include LevoCap ER, d-Methadone, MepiGel, and BuTab ER. LevoCap ER is a proprietary once-a-day extended release dosage form of the opioid analgesic levorphanol. LevoCap ER is in an abuse deterrent drug delivery system. It is a new tamper-resistant, extended release form of levorphanol.
Relmada Therapeutics’ d-Methadone is the d optical isomer of racemic methadone and an antagonist at the N-methyl-D-aspartate (NMDA) receptor. Furthermore, the Company’s MepiGel is a proprietary topical dosage form of the local anesthetic mepivacaine for the treatment of painful peripheral neuropathies.
Relmada’s BuTab ER is a proprietary once-a-day extended release dosage form of oral buprenorphine. It is undergoing development for the treatment of chronic moderate to moderately severe pain and opioid dependence.
Relmada Therapeutics entered into an agreement with Memorial Sloan Kettering Cancer Center (MSKCC) in a series of animal studies for levorphanol, the active ingredient of LevoCap ER. Gavril Pasternak, MD, PhD, of MSKCC is the lead investigator for these studies.
Last month, Relmada Therapeutics announced that it received a No Objection Letter (NOL) from Health Canada to conduct the first pharmacokinetic study with novel formulations of oral, enteric-coated buprenorphine (BuTab, REL-1028) undergoing development for the treatment of chronic pain and opioid dependence.
Today, Relmada Therapeutics announced that it received clearance from Health Canada to continue dose escalation and explore higher doses of d-Methadone (REL-1017), its N-methyl-D-aspartate (NMDA) receptor antagonist undergoing development for the treatment of neuropathic pain. In the Phase 1 pharmacokinetic and pharmacodynamic study in healthy volunteers not previously exposed to opioid therapy, d-Methadone demonstrated a good safety profile with no dose-limiting side effects after the original four cohorts were exposed to increasingly higher doses.
The trial will continue dose-escalation with the additional cohorts. The goal of the initial Phase 1 study is to evaluate the safety, tolerability, pharmacodynamics, as well as pharmacokinetics of oral single ascending doses of d-Methadone (REL-1017) in healthy subjects. This is to establish a Maximum Tolerated Dose (MTD).
Relmada Therapeutics, Inc. (RLMD), closed Thursday's trading session at $2.55, up 0.79%, on 297,725 volume with 384 trades. The average volume for the last 60 days is 134,206 and the stock's 52-week low/high is $1.50/$4.00.
Guided Therapeutics, Inc. (GTHP)
SmallCapVoice reported earlier on Guided Therapeutics, Inc. (GTHP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Norcross, Georgia-headquartered Guided Therapeutics, Inc. is the creator of a rapid and painless testing platform. This platform is for the early detection of disease based on the Company's patented biophotonic technology, which employs light to detect disease at the cellular level. Guided Therapeutics’ first product is the LuViva® Advanced Cervical Scan. This is a non-invasive device used to detect cervical disease instantly and at the point of care. Guided Therapeutics’ shares trade on the OTC Bulletin Board.
The design of LuViva® is as a fast, painless test that, unlike Pap smears and HPV testing, does not require a tissue sample or the delay of laboratory analysis. The Guided Therapeutics LuViva® Advanced Cervical Scan is an investigational device and is limited by federal law to investigational use.
LuViva® is a technologically advanced diagnostic device. It scans the cervix with light and employs spectroscopy to measure how light interacts with the cervical tissue. Spectroscopy identifies chemical and structural indicators of pre-cancer that may be below the surface of the cervix or misdiagnosed as benign. This technique goes by the name biophotonics. Biophotonics is the science of generating and harnessing light to image, detect, and manipulate biological materials.
In a multi-center clinical trial, with women at risk for cervical disease, the LuViva® Advanced Cervical Scan technology was able to detect cervical cancer up to two years earlier than conventional modalities, according to published reports. The device is used in combination with the LuViva® Cervical Guide single-use patient interface and calibration disposable.
The LuViva® Advanced Cervical Scan is now compliant with Edition 2 and Edition 3 CE standards. It has marketing approval from Health Canada and the Singapore Health Sciences Authority. It is under U.S. Food and Drug Administration (FDA) Premarket review. The Company is also developing a non-invasive test for the early detection of esophageal cancer using the technology platform.
Last week, Guided Therapeutics announced it shipped two LuViva® Advanced Cervical Scans to Indonesia to commence cervical cancer screening evaluations in the world’s fourth most populous nation. Indonesia has greater than 63 million women ages 25 to 64.
Yesterday, Guided Therapeutics announced it completed the sale of 4.0 million shares of its common stock and warrants to purchase an additional 2.0 million shares, for a total purchase price of $720,000 in a private placement to accredited investors.
In combination with the investment, Guided Therapeutics and investors signed a Letter of Intent (LOI) to negotiate the exclusive distribution rights for the LuViva® Advanced Cervical Scan in China. The LOI calls for the sale of five LuViva devices and associated single use disposables to Hong Kong and China, for clinical testing and regulatory evaluation. An additional non-dilutive payment of $55,000 is due to Guided Therapeutics before the end of this month, which activates the shipment of the first two of these devices.
Guided Therapeutics, Inc. (GTHP), closed Thursday's trading session at $0.187, up 24.67%, on 713,718 volume with 113 trades. The average volume for the last 60 days is 194,994 and the stock's 52-week low/high is $0.1291/$0.60.
Oxford City Football Club, Inc. (OXFC)
InvestorPlace reported previously on Oxford City Football Club, Inc. (OXFC), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.
Oxford City Football Club, Inc. is a diversified holding company that lists on the OTC Markets Group’s OTCQB. The Company manages a controlling interest in several portfolio companies across a range of sectors, including Sports, Education, Media & Entertainment, and Real Estate & Property Management. The Company previously went by the name WMX Group Holdings, Inc. It changed its name to Oxford City Football Club, Inc. in July of 2013. The Company is headquartered in Deerfield Beach, Florida and it also has a UK Headquarters in Oxford, England.
Oxford City Football Club is the largest publicly traded diversified portfolio of professional sports teams globally. It owns a 131-year-old professional football club Oxford City FC, which plays in the Conference North Division of the English Football Association.
In addition, it owns Oxford City Nomads, which plays in the Hellenic League Premier Division of the English Football Association. Furthermore, Oxford City owns Oxford City Futsal, which plays at the highest level of Futsal in England. Moreover, the Company owns a varied portfolio of academic institutions. It owns Oxford City University and Oxford City Sports College in the U.S.
Oxford City Football Club has acquired all of AlvaEDU's assets in a $7M equity deal. With the acquisition of AlvaEDU's assets and Intellectual Property (IP), Oxford City will acquire a global leader in education technology. The focus of AlvaEDU is on improving higher education via technology.
Today, Oxford City Football Club announced that it has established a specific plan to establish a strong earnings per share and a sustainable revenue stream for the future. If successful, it hopes to be in a position to meet the minimum listing standard at the NYSE. It has established a partnership with an accredited University to deliver its CIT University's Masters Degree Program in Sports Management. Its recent deal with AlvaEDU permits it 100 percent of the revenue generated from tuition fees.
Oxford City Football Club, Inc. (OXFC), closed Thursday's trading session at $0.055, up 83.95%, on 1,147,808 volume with 109 trades. The average volume for the last 60 days is 28,442 and the stock's 52-week low/high is $0.023/$12.50.
SPYR, Inc. (SPYR)
Whisper from Wall Street, Otcstockexchange, Penny Stock General, Stock Shock and Awe, and Fast Money Alerts reported this month on SPYR, Inc. (SPYR), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.
Abtech Holdings, Inc. is a full-service environmental technologies and engineering firm. AbTech Industries, Inc. is a subsidiary of AbTech Holdings. It offers creative solutions to communities, industry, and governments addressing issues of water pollution and contamination. The Company offers solutions for Stormwater Management, Oil & Gas Water Treatment, and Industrial Water Treatment. Abtech Holdings is headquartered in Scottsdale, Arizona.
Moreover, AEWS Engineering is a subsidiary of Abtech Holdings. AEWS is an independent civil and environmental engineering firm partnered with top research and engineering universities. The foundation of Abtech’s products are on polymer technologies that can remove hydrocarbons, sediment, and other foreign elements in stormwater runoff, flowing water, and industrial process and wastewater.
Abtech Holdings integrates its native advanced technologies along with third-party technologies and systems to provide effective and economical solutions to its customers. Abtech started marketing of produced water and industrial wastewater treatment, and established its engineering subsidiary AEWS Engineering in 2012.
The Company’s offerings include the antimicrobial technology- Smart Sponge® Plus. This technology is effective in reducing coliform bacteria found in stormwater, industrial wastewater, and municipal wastewater. Smart Sponge® Plus is registered with the Environmental Protection Agency (EPA).
Abtech Holdings reported in October 2013, that Nassau County, Long Island, New York, fully executed a Not-To-Exceed (NTE) $12 million contract with the Company’s subsidiary, AbTech Industries, for the nation's initial design-build-operate (DBO) storm water management project. The project was originally awarded July 1, 2013. The contract has a three year term with a provision for up to two years of operations and maintenance. AbTech announced in August 2014 that it completed Phase 1 of the $12 million NTE stormwater management contract in Nassau County.
Abtech has deployed and validated onsite its first mobile water pre-treatment system, focused on oil recovery and hydrocarbon removal for the treatment of flowback and produced water for the on-shore Oil & Gas industry. This pre-treatment system integrates its Smart Sponge® technology. The design of it is to operate in advance of other treatment systems, increasing overall efficiency and lowering treatment cost.
This past February, Abtech Holdings announced that it received from the Commissioner of Public Works of Nassau County, New York, a notice to proceed with completion of the engineering design services for the first County-owned stormwater site to be outfitted with a stormwater treatment device under the $12 million NTE (Not-To-Exceed) stormwater management contract awarded to AbTech by Nassau County in October 2013. Work will begin immediately on the site situated beneath Marjorie Lane, East Rockaway in Bay Park Long Island, New York.
Abtech also has a collaboration agreement with Corvias Solutions to establish a framework for development of large stormwater infrastructure projects with an immediate focus on Northeastern municipalities. The most notable contract is the initial $100 million Prince George's County, Maryland, expected to start work this year. Corvias Solutions is a large national developer, program manager and facility owner/operator.
SPYR, Inc. (SPYR), closed Thursday's trading session at $0.64, up 3.26%, on 154,835 volume with 117 trades. The average volume for the last 60 days is 24,735 and the stock's 52-week low/high is $0.10/$0.74.
Pure Hospitality Solutions, Inc. (PNOW)
The QualityStocks Daily Newsletter would like to spotlight Pure Hospitality Solutions, Inc. (PNOW). Today, Pure Hospitality Solutions, Inc. closed trading at $0.0017, on 337,151 volume with 38 trades. The stock’s average daily volume over the past 60 days is 128,130, and its 52-week low/high is $0.0701/$0.28.
Pure Hospitality Solutions, Inc. announced today, that the Company has made major corporate adjustments that briefly postponed its year-end filings. "In directing our attention to the 2015/2016 $30 plus billion dollar Latin American online travel market, as previously mentioned, we intended to make some bold adjustments to our business strategy," stated Melvin Pereira, President of Pure Hospitality Solutions, Inc. "And we most certainly did! Unfortunately in doing so, we have triggered a few subsequent events that will significantly impact our audit and has extended the Company past its filing dates. We will however, have the updated disclosures completed and filed within the upcoming week."
Pure Hospitality Solutions, Inc. (PNOW) is a provider of proprietary technology, marketing solutions, infrastructure and branding services to hotel operators.
The company's innovative platform functions as a powerful vehicle to help hotel operators achieve greater success in three specific areas: (i) expanded international exposure and recognition, (ii) powerful core structure, and (iii) high occupancy rates that drive increases in bottom-line profits. Pure continuously refines its suite of proprietary solutions to deliver measurable and proven results to hotel properties. This success has been reflected in those properties operating under the Hotel PURE brand as well as with independent boutique hotel properties utilizing the company's Friendly Reservation Online (FROL) booking engine technology and internet marketing services.
Operating a successful bi-lateral business model, Pure has four objectives:
1. To franchise the Hotel PURE brand to selected hotel properties worldwide similar to the business model currently employed by Big Brand operators such as Holiday Inn, Marriott, Sheraton and others;
2. Provide highly efficient and economical back-end booking engine technology services to independently branded boutique hotels that require a robust online presence;
3. Launch a stand-alone online hotel booking search engine primarily focused on Central America; and,
4. Expand the portfolio of Pure-owned boutique hotels operating under the Hotel PURE brand.
The company initially began growing its operations primarily in the United States. However most recently, major opportunities in Central America began presenting themselves, giving Oriens the ability to retool its business model. Now the company is positioned to acquire, own and operate its own properties – which would be marketed under the new brand with occupancies handled by the re-launched online booking engine system.
Ultimately, Pure intends to become a top-tier hotel brand operator and Internet booking and marketing service provider, qualifying as a preferred supplier to lending institutions. The company also intends to establish an invaluable international footprint with its online booking engine technology and marketing offerings; making that segment of its business a prime acquisition target for major online travel search and booking engine companies. Advancement toward this goal is guided by an executive management team with deep expertise in technology, banking, management, hospitality, branding and marketing, technical development and more. Disclaimer
Pure Hospitality Solutions, Inc. Company Blog
Pure Hospitality Solutions, Inc. News:
National Tourism Center Of Costa Rica Gives Pure Opportunity
Pure's Oveedia Signs First Property
Pure Retains Softon to Accelerate Photo Share Software
Zenosense, Inc. (ZENO)
The QualityStocks Daily Newsletter would like to spotlight Zenosense, Inc. (ZENO). Today, Zenosense, Inc. closed trading at $0.17, up 30.37%, on 122,532 volume with 30 trades. The stock’s average daily volume over the past 60 days is 26,541, and its 52-week low/high is $0.13/$0.95.
Zenosense, Inc. (ZENO) is developing and intends to market a novel device to enable hospitals to detect Methicillin-resistant Staphylococcus Aureus (MRSA) bacterial contamination, a major constituent of Hospital Acquired Infections (HAIs). The annual costs of treating hospitalized MRSA patients are estimated to be between $3.2 billion and $4.2 billion in the United States alone. MRSA infected patients are likely to spend three times as long in a hospital stay at three times the cost, and are five times more likely to die than an uninfected patient.
Early detection of MRSA and HAIs in general is vital. Recent studies suggest that implementing prevention practices can lead to up to a 70 percent reduction in certain HAIs with a financial benefit of using these prevention practices estimated to be as high as $25.0 billion to $31.5 billion in medical cost savings in the United States alone (according to a report by the Centers for Disease Control and Prevention, part of the US Department of Health and Human Sciences). Currently, no cost effective early detection device is available.
The Zenosense MRSA detection device is expected to act like a “smoke detector” for MRSA; designed to detect MRSA in the environment or infected patient, even before a patient demonstrates any obvious symptoms, satisfying this huge unmet need.
Zenosense has an agreement with leading European sensor developer Sgenia Group, which is developing such a device exclusively for Zenosense through their subsidiary Zenon Biosystem. The estimated manufacturing cost per device is under $100 USD and possibly as low as $50 USD. The Zenosense device, utilizing established Sgenia programming and patent-pending hardware, utilizes a single sensor to perform an infinite number of scans, creating tens of thousands of "virtual sensors". The low cost and compact design of the Zenosense device, if successfully developed, would make it possible to be worn by individuals, as well as placed in numerous sensitive areas in the healthcare setting.
Zenosense has a streamlined management team experienced in high-level marketing in the medical sector, supported by the outsourced Zenon Biosystem scientific/development team of qualified personnel with extensive knowledge and experience in the development of sensors. Both of these teams will fuse together through a high level advisory board of experienced professionals. A cost-effective Zenosense MRSA detection device, once developed, is expected to be in high demand, driven by patient safety, cost and insurance considerations. Disclaimer
Zenosense, Inc. Company Blog
Zenosense, Inc. News:
Zenosense, Inc. - Hospital Collaboration - 400 Person Lung Cancer Detection Trial
Zenosense, Inc.; Stock Now DTC DWAC/FAST Eligible
Zenosense, Inc. Reports Manufacturing of Pre-Commercial Lung Cancer Detection Device
Well Power Inc. (WPWR)
The QualityStocks Daily Newsletter would like to spotlight Well Power Inc. (WPWR). Today, Well Power Inc. closed trading at $0.006, up 3.45%, on 1,395,289 volume with 15 trades. The stock’s average daily volume over the past 60 days is 610,295, and its 52-week low/high is $0.005/$0.2789.
Well Power Inc. (WPWR) has secured the licensing rights to Texas with the first right of refusal on the other US states to a new technology solution to process waste natural gas, such as vented, flared or stranded gas, into “clean power” and engineered fuels, including no-sulphur diesel and diluents. Based on proprietary technology, this solution is mobile, high-yield and can be deployed with minimum capital expenditure.
The company plans to be able to provide its technology with full-service engineering, design, construction, modular fabrication, maintenance and construction management services to clients in the upstream areas of exploration and production. Well Power will also offer consulting services, process assessments, facility appraisals, feasibility studies, technology evaluations, project finance structuring and support, and multi-client subscription services.
Approximately 2.4 million barrels of oil equivalent is wasted each day by gas flaring alone, resulting in $10 billion of lost revenue and 400 million metric tons of CO2 equivalent global greenhouse gas emissions each year. Additionally, environmental degradation associated with gas flaring has been shown to have a significant impact on local populations, often resulting in loss of livelihood and severe health issues.
Well Power’s Micro Refinery Unit (MRU) offers the opportunity to create value from a wasted resource while simultaneously enabling wider access to energy, improved environmental conditions, and economic development for local populations. By eliminating legacy flaring and minimizing new flaring, the company is well positioned to take a leadership role in the ongoing push for sustainable resource development and energy efficiency. Disclaimer
Well Power Inc. Company Blog
Well Power Inc. News:
Well Power Inc. Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors
Well Power - Letter from President to Shareholders
Well Power Inc. to host second webinar on proprietory micro-refinery technology
Inventergy Global, Inc. (INVT)
The QualityStocks Daily Newsletter would like to spotlight Inventergy Global, Inc. (INVT). Today, Inventergy Global, Inc. closed trading at $0.381, off by 3.86%, on 192,496 volume with 227 trades. The stock’s average daily volume over the past 60 days is 383,432, and its 52-week low/high is $0.353/$10.52.
Inventergy Global, Inc. (INVT) is an intellectual property (IP) licensing partner specializing in IP value creation. Led by industry veteran Joe Beyers, former head of global licensing for Hewlett-Packard, Inventergy identifies, acquires and licenses patented technologies to help market-leading technology companies monetize and achieve more value from their innovations.
With more than 100 years of combined experience and track record of handling more than $15 billion in IP and technology transactions, Inventergy’s team of professionals handle every aspect of the IP business, from valuation and branding through legal analysis, decision making and patent sales.
Inventergy partners with world-class, market-significant companies who may lack internal manpower, budget or other resources necessary to realize appropriate return-on-investment. Through collaborative, business-centered, and forward-thinking strategies, Inventergy is able to create portfolios with significant market potential and optimize the innovator’s overall return-on-investment.
The company has established a network of key industry relationships to complement its solid licensing model and growing portfolio of assets, which currently stands at more than 760 global patent assets. Inventergy pursues maturing telecommunications technologies already adopted in the marketplace and earning accretive value. Disclaimer
Inventergy Global, Inc. Company Blog
Inventergy Global, Inc. News:
Inventergy Announces $2.15 Million Common Stock Financing to Accelerate Licensing Operations
Inventergy Announces CEO & Chairman Joe Beyers to Present at IPBC Global 2015, San Francisco
Inventergy Announces Operational Restructuring of Its Product Businesses Designed to Improve Margins, Cash Flow and Earnings Growth
Car Monkeys Group (CKMY)
The QualityStocks Daily Newsletter would like to spotlight Car Monkeys Group (CKMY). Today, Car Monkeys Group closed trading at $0.16, even for the day, on 5,000 volume with 1 trade. The stock’s average daily volume over the past 60 days is 1,465, and its 52-week low/high is $0.10/$5.00.
Car Monkeys Group (CKMY), via CarMonkeys.com, is one of the largest and fastest growing online cars, vans and SUV parts distributors in the United States. Founded in 2010, the Wyckoff, New Jersey-based company formerly was known as Delaine Corporation and changed its name to Car Monkeys Group in February 2015.
With access to hundreds of thousands of parts, Car Monkeys sells used, high-quality, low-mileage automotive parts to consumers, retailers, truck and car fleet owners and auto repair facilities looking for a wide range of vehicle makes and models. Customers have access to a Part Finder section that helps them easily navigate and quickly locate the right parts they need.
Striving to provide customers a quick, hassle-free and convenient shopping experience, all parts ordered through CarMonkeys.com ship from one of the company’s numerous distributors and auto dismantling centers straight to the customer or their mechanic. Advantages such as a five-year unlimited mileage warranty, zero shipping costs, and a generous return policy further contribute to the increasing popularity of the Car Monkeys brand.
Automotive recycling plays a substantial role in the preservation of natural resources and reduction of demand for landfill space. According to the Automotive Recyclers Association, approximately 95% of vehicles retired from use are processed for recycling, saving an estimated 85 million barrels of oil that would have been used to manufacture new or replacement parts. As a rapidly growing and trusted automotive recycling company, Car Monkeys is positioned as a leading player in the broader $22 billion North American automotive recycling industry. Disclaimer
Car Monkeys Group Company Blog
Car Monkeys Group News:
Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services
Car Monkeys Group (CKMY) is “One to Watch”
Car Monkeys Group (CKMY) Continues Growth as one of the Country’s Largest Online Automobile Parts Distributors
Save The World Air, Inc. (ZERO)
The QualityStocks Daily Newsletter would like to spotlight Save The World Air, Inc. (ZERO). Today, Save The World Air, Inc. closed trading at $0.42, even for the day, on 96,356 volume with 31 trades. The stock’s average daily volume over the past 60 days is 117,012, and its 52-week low/high is $0.3401/$0.88.
Save The World Air, Inc. (ZERO) (“STWA”) provides the global energy industry with patent-protected industrial equipment designed to deliver measurable performance improvements to crude oil pipelines. Developed in partnership with leading crude oil production and transportation entities, STWA’s high-value solutions address the enormous capacity inadequacies of domestic and overseas pipeline infrastructures that were designed and constructed prior to the current worldwide surge in oil production.
In support of our clients’ commitment to the responsible sourcing of energy and environmental stewardship, STWA combines scientific research with inventive problem solving to provide energy efficiency ‘clean tech’ solutions to bring new efficiencies and lower operational costs to the upstream, midstream and gathering sectors. STWA’s flagship product, AOT (Applied Oil Technology) improves the economics of transporting crude oil by reducing the viscosity of oil in pipelines. Once deployed on pipeline pumping stations, production and transportation companies benefit from the safer, more cost-effective delivery of greater volumes of oil while reducing energy consumption at pumping stations and lowering CO2 emissions.
The AOT technology is the result of years of research conducted at Temple University (Philadelphia, Penn.) and is the world’s first ASME-certified industrial hardware to use the principles of electrorheology, the study of applying non-uniform electrical fields to change the mechanical behavior of fluids, to significantly reduce the viscosity of crude oil within pipelines during maximum flow conditions. Field tested by the U.S. Department of Energy, independent testing laboratories such as ATS RheoSystems and fabricated to exacting industry standards by STWA’s supply chain partners, the efficacy of AOT to increase flow rates, prevent bottlenecks, reduce pump station power consumption, enhance pipeline integrity and optimize flow assurance has been proven repeatedly in the lab and on a 300,000 barrel per day pipeline.
STWA is also commercializing STWA Joule Heat, an energy-efficient technology for heating crude oil in pipelines to improve flow. Unlike traditional trace heating systems which generate heat via a resistive trace heating element which transfers energy into the oil, the STWA solution applies an electrical field directly to oil, generating heat within the flow itself. The result is optimal heat conductivity and performance with less power and in a smaller form factor.
Guided by a dynamic management team led by Greggory Bigger, Chief Executive Officer, Chairman and a strong independent board of directors of energy industry veterans, STWA is a revenue generating company with a solid cash position, clean balance sheet and a proven ability to develop and deliver industrial-grade equipment that support the company’s mission and enhance shareholder value. As the exclusive licensee of oil viscosity reduction processes developed at Temple University and owner of 48 worldwide patents related to the use of electricity to change the mechanical behavior of oil and liquid natural gas, STWA is well-positioned to capitalize on the explosive growth opportunities in the global crude oil production and transportation sector. More information is available at: www.stwa.com. Disclaimer
Save The World Air, Inc. Company Blog
Save The World Air, Inc. News:
STWA Selected as a Finalist for the 2015 Global Petroleum Show Awards
STWA Reports 2014 Year-End Financial Results and Provides Operational Update
STWA Sets Date for Its Year-End 2014 Earnings Results Release and Conference Call
International Stem Cell Corp. (ISCO)
The QualityStocks Daily Newsletter would like to spotlight International Stem Cell Corp. (ISCO). Today, International Stem Cell Corp. closed trading at $0.0575, even for the day, on 639,782 volume with 60 trades. The stock’s average daily volume over the past 60 days is 670,488, and its 52-week low/high is $0.045/$0.19.
International Stem Cell Corp. (ISCO) specializes in the therapeutic applications of human stem cells and the development and commercialization of cell-based biomedical products. The company was the first to develop and perfect a new class of human stem cells called parthenogenetic stem cells, created from unfertilized human eggs. ISCO has a strong patent portfolio offering clean intellectual property and freedom to operate. The company’s stem cells present superior immune matching capabilities and can be used in millions of people regardless of sex or racial background, with minimal expectation of immune rejection after transplantation.
The company’s human stem cells have been shown to be as pluripotent as embryonic stem cells, however their creation does not involve the destruction of a viable human embryo, which effectively sidesteps the controversy and ethical dilemmas associated with the use of human embryonic stem cells. In contrast to induced pluripotent stem cells, ISCO’s stem cells do not involve manipulation of cells’ genome thereby avoiding potential safety and regulatory obstacles in clinical applications.
The company's scientists are currently focused on using its stem cells to treat severe unmet medical needs of the central nervous system (Parkinson’s disease), the liver and the eye, where cell therapy has been clinically proven but is limited due to the unavailability of safe human cells. Once the technology has been clinically validated there are an essentially unlimited number of potential applications. Because of their immune-matching ability a relatively small number of these stem cell lines could offer the potential of producing the first true stem cell bank as a means of serving populations of different immune types across the globe.
In addition to its therapeutic focus, ISCO also provides a growing revenue stream through two wholly owned subsidiaries. Lifeline Cell Technology specializes in producing primary human cells and growth media for biological research, and Lifeline Skin Care, the company manufactures and markets advanced anti-aging skincare products utilizing the company’s expertise in stem cell biology. Disclaimer
International Stem Cell Corp. Company Blog
International Stem Cell Corp. News:
International Stem Cell Corporation Presents Data From Parkinson's Disease Program at AAN Annual Meeting
International Stem Cell Corporation Demonstrates Reversal of Neurological Stroke Symptoms Using Neural Stem Cells
International Stem Cell Corporation Announces 2014 Fourth Quarter and Year-End Results
Today's Top 3
INO.com Market Report
The QualityStocks Public Company Sponsor News
- Get profiles for new featured companies at clients.qualitystocks.net
- Car Monkeys Group (CKMY) Announces Engagement of QualityStocks Investor Relations Services
- Cleartronic, Inc. (CLRI) Adds Shareholder Value With Cancellation of Two Billion Shares of Common Stock Held by CEO
- Consorteum Holdings, Inc. (CSRH) Signs License Agreement With NYG Holdings
- Dominovas Energy Corp. (DNRG) Key Management Featured in Exclusive QualityStocks Interview
- Falcon Crest Energy (FCEN) Acquires Remaining Working Interest in Rocky Ford Field
- IFAN Financial, Inc. (IFAN) Expands Board of Directors With Addition of Technology Venture Veteran
- International Stem Cell Corp. (ISCO) Presents Data From Parkinson's Disease Program at AAN Annual Meeting
- Inventergy Global, Inc. (INVT) Announces $2.15 Million Common Stock Financing to Accelerate Licensing Operations
- MIT Holding, Inc. (MITD) Launches New Website with Investor Relations Suite
- Mobile Lads Corp. (MOBO) Begins Operating And Buys Control Of North American Shopping Network Simbadeals.com From DoMark International
- One World Holdings, Inc. (OWOO) Raises Capital to Fund National Expansion and Convertible Note Elimination
- Pure Hospitality Solutions, Inc. (PNOW) National Tourism Center Of Costa Rica Gives Pure Opportunity
- Save The World Air, Inc. (ZERO) Reports 2014 Year-End Financial Results and Provides Operational Update
- Sibling Group Holdings, Inc. (SIBE) Strategic Partner Shenzhen Times Increases Stake in Sibling Group; $5,500,000 Warrant Exercise to Fund Growth Initiatives
- Sparta Commercial Services, Inc. (SRCO) iMobileApp's Customer Base Continues to Diversify
- VistaGen Therapeutics, Inc. (VSTA) and NIH Sign Agreement for NIH-Sponsored Phase 2 Study of Orally-Active AV-101 in Major Depressive Disorder
- Well Power Inc. (WPWR) Appoints Professional Engineer, Oil & Gas Veteran to Board of Directors
- Zenosense, Inc. (ZENO) Hospital Collaboration - 400 Person Lung Cancer Detection Trial